Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
about
Predicting a post-thrombolysis intracerebral hemorrhage: a systematic reviewUpdate on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients.Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.Blood biomarkers of ischemic stroke.Effects of alteplase in the treatment of acute ischemic stroke.Hyperglycemia in acute ischemic stroke: a vascular perspective.Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?Applicability of biomarkers in ischemic stroke.Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseasesRNA in blood is altered prior to hemorrhagic transformation in ischemic strokeThe HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis.Safety and efficacy of alteplase in the treatment of acute ischemic strokeElevated Homocysteine Level Related to Poor Outcome After Thrombolysis in Acute Ischemic Stroke.Molecular biomarkers in stroke diagnosis and prognosis.Hemorrhagic transformation after ischemic stroke in animals and humansInvited article: searching for oracles? Blood biomarkers in acute stroke.Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke.Evolving role of biomarkers in acute cerebrovascular disease.Clinical predictors and management of hemorrhagic transformation.Ischemic stroke biomarkers in blood.Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study.Potential biomarkers for predicting hemorrhagic transformation of ischemic stroke.Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.Long-term outcomes of post-thrombolytic intracerebral hemorrhage in ischemic stroke patients.The effect of recombinant tissue plasminogen activator on MMP-2 and MMP-9 activities in vitro.Plasma thrombin-activatable fibrinolytic inhibitor (TAFI) among healthy subjects and patients with vascular diseases: a validation study.The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population.
P2860
Q26830834-D78994D9-B9D5-47EE-9007-1A9DC442B416Q35109940-1721BC1E-AA8C-4B86-8B79-58453FB3FAB1Q35567319-D466AF12-02E9-495E-85CE-5E57C2D92019Q35648087-E9A7741D-8EDA-4573-B025-B3B67A93EB25Q36283936-D0FDBFBC-001C-4673-BA8B-7C29C4B9657DQ36521250-B5CA2F07-D4CB-486A-A86D-A1BA7EE55190Q36738090-65B64CF5-497C-4533-82A8-4F412592D808Q36843336-DC1B38A5-FE62-49BA-B311-18922FC158E4Q36986354-087B3FA3-DD42-40E8-91BA-9646E0EB444EQ37017506-45D08A0D-85F8-4460-B949-C05BE2C74F28Q37118070-8994C7BC-FB26-4ED5-B5E2-4D8C190864E4Q37179002-F9D0FC95-353C-4D35-9A08-9F8B6C57593CQ37202149-4FB62B38-0BD5-4F84-A647-3F2F15EED9D9Q37279555-293D34F5-4D0B-4601-B64E-78EB0B451795Q37408830-63C83E0F-4032-48C9-AB42-5B0B46927A38Q37559355-AE4B9B21-EB9C-48A9-B399-6E62F818553DQ37571237-6A1D5962-6C5C-4B10-BDA2-DA674FD07961Q37701498-330280C5-47F4-4050-9411-6AADC82D73F6Q37838426-527A4C1B-E664-4ACD-9E7D-5602830CF465Q37997374-4EFD0FB4-BC27-45AC-8D6B-49EB326CBCF5Q38074569-8C7D751F-7597-4FD4-A903-80346ABC4236Q38079618-6736DBD6-DE2C-4B1B-B1C6-C9217C159CE3Q38317059-ADB08A71-B36F-400E-8A2B-2E4D295A6A6BQ39447215-5E73A11A-21EC-4B6D-84DC-9B76123C2CE4Q43274552-72D0363E-44A7-40A8-BDA0-2298045B5F6FQ43702546-0651C5AE-AB32-4A4C-A856-267DA037DA5BQ48696369-4B5106C7-6F3A-477E-BD8C-CD080BA8657AQ49080002-FE21C15A-90AE-4697-82CE-FD3094E83ADDQ53320932-82378A69-20EB-43A4-A332-D3A128A51D80
P2860
Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Admission fibrinolytic profile ...... tissue plasminogen activator.
@en
type
label
Admission fibrinolytic profile ...... tissue plasminogen activator.
@en
prefLabel
Admission fibrinolytic profile ...... tissue plasminogen activator.
@en
P2093
P50
P1433
P1476
Admission fibrinolytic profile ...... h tissue plasminogen activator
@en
P2093
Carlos A Molina
Esteban Santamarina
Juan F Arenillas
Manuel Quintana
P304
P356
10.1161/01.STR.0000137608.73660.4C
P407
P577
2004-07-08T00:00:00Z